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OBJECTIVE — To determine the association between 25-hydroxyvitamin D (25-OHD) con-
centration and risk of incident type 2 diabetes.
RESEARCH DESIGN AND METHODS — In a nested case-control study conducted
among608womenwithnewlydiagnosedtype2diabetesand559controlsubjectsintheNurses’
HealthStudy,wemeasuredtheassociationbetweenbaselineplasma25-OHDconcentrationand
risk of incident diabetes.
RESULTS — After adjusting for matching factors and diabetes risk factors, including BMI,
higher levels of plasma 25-OHD were associated with a lower risk for type 2 diabetes. The odds
ratio for incident type 2 diabetes in the top (median 25-OHD, 33.4 ng/ml) versus the bottom
(median 25-OHD, 14.4 ng/ml) quartile was 0.52 (95% CI 0.33–0.83). The associations were
consistent across subgroups of baseline BMI, age, and calcium intake.
CONCLUSIONS — Plasma 25-OHD concentration was associated with lower risk of inci-
dent type 2 diabetes in women.
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G
rowing evidence indicates that sub-
optimalvitaminDstatusmayplaya
role in the development of type 2
diabetes (1). Results from longitudinal
observationalstudiessupportthehypoth-
esisthatlowvitaminDstatusisassociated
with development of type 2 diabetes;
however, only one study has examined
the association between blood 25-
hydroxyvitamin D (25-OHD) concentra-
tion and incident type 2 diabetes, and
there was no signiﬁcant association
among women (2,3). We examined pro-
spectivelytheassociationbetweenplasma
25-OHD concentration and risk of inci-
dent type 2 diabetes among women in a
case-control study nested within the
Nurses’ Health Study (NHS).
RESEARCH DESIGN AND
METHODS— TheNHSisalarge,lon-
gitudinal ongoing cohort of U.S. female
nurses who respond to questionnaires
mailed every 2 years to update informa-
tion on health-related behavior and to
identify incident disease (4). During
1989–1990, 32,826 women aged 43–70
years, who were free of diagnosed diabe-
tes,coronaryheartdisease,stroke,orcan-
cer, provided blood samples. Through
June 2004, 1,106 of these women had a
conﬁrmed diagnosis of type 2 diabetes
and were classiﬁed as case participants.
For each case, control participants pro-
vidingbloodsamplesduringthesamepe-
riod were selected and matched by age,
race, fasting status at blood draw, and
date of blood draw. After excluding
women with unavailable information on
25-OHD, the ﬁnal analytical sample con-
sisted of 608 case and 569 control sub-
jects. Plasma 25-OHD was measured by
the
125I radioimmunoassay procedure
(DiaSorin,Stillwater,MN),withmeanco-
efﬁcient of variation of 8.5% (intra-assay)
and 8.7% (interassay).
For external validation, the labora-
tory participated in the vitamin D Exter-
nal Quality Assessment Scheme (http://
deqas.org). Matched case-control pairs
were handled identically and assayed in
the same analytical run by personnel
blinded to the case-control status of the
samples.Measurementsweredoneinran-
domorderandinduplicatetoreducesys-
tematic error and interassay variability.
Incident cases of type 2 diabetes were
identiﬁedbyself-reportandconﬁrmedby
a supplementary questionnaire, as previ-
ously reported (5). BMI, physical activity,
and smoking status; family history of di-
abetes in a ﬁrst-degree relative; and phy-
sician-diagnosed hypertension and
hypercholesterolemia were self-reported.
Physical activity was computed as meta-
bolic equivalents (METs) per week based
on average time spent per week on vari-
ous leisure-time activities, weighted by
their intensity level (5). Information on
dietary intake was obtained from the
semiquantitative validated food fre-
quency questionnaire (6). Total nutrient
intakes were calculated by adding intake
fromdifferentfoodsourcestointakefrom
multivitaminsandsupplements.Intakeof
nutrients was adjusted for total energy in-
take with regression analysis (5).
We calculated odds ratios (ORs) for
type2diabetesusingunconditionallogis-
tic regression analysis adjusted for the
matching factors, latitude of participants’
residence, and laboratory batch for 25-
OHD assay. We also adjusted for known
and suggested risk factors for type 2 dia-
betes. We used restricted cubic spline re-
gression with three knots to examine for
possible nonlinear relation of 25-OHD
with incident type 2 diabetes (7).
RESULTS— The mean age of the co-
hort was 56.4 years, BMI was 27.8 kg/m
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25-OHD was higher among white than
nonwhite subjects (23.0 vs. 21.4 ng/ml,
respectively, P  0.016) and among nor-
mal-weight than overweight/obese
women(24.4vs.21.7ng/ml,respectively,
P  0.001). Total vitamin D intake was
321 IU/day without difference between
case and control subjects. After multivar-
iate adjustment, the OR for incident dia-
betesinthetopversusthebottomquartile
for 25-OHD concentration was 0.52
(95% CI 0.33–0.83; P for trend  0.008)
(Table 1). Spline regression models
showed no apparent threshold and no de-
viation from linearity for the relation be-
tween 25-OHD and risk of incident type 2
diabetes (Pfor linearity 0.015), although
the shape of the ﬁgure suggested a stronger
decrease in risk within the higher range of
25-OHD concentration (online ap-
pendix ﬁgure, available at http://care.
diabetesjournals.org/cgi/content/full/dc10-
0790/DC1). The associations were
consistent across all subgroup analyses,
with the exception of the subgroup
analyses by BMI. The association was
stronger among overweight/obese
women (0.46 [0.25–0.83]; P for
trend  0.016) compared with normal-
weight women, where the association
was in the same direction but was not
statistically signiﬁcant (BMI 25 kg/
m
2; 0.63 [0.25–1.56]; P for trend 
0.24) (online appendix Table).
CONCLUSIONS — In this nested
case-control study of middle-aged
women, plasma 25-OHD concentration
was inversely associated with develop-
ment of type 2 diabetes, independent of
known diabetes risk factors, including
age, BMI, and race. To our knowledge,
this study is the largest observational lon-
gitudinal study that used blood 25-OHD
concentration to assess vitamin D status
prior to development of type 2 diabetes
and the ﬁrst one that reported such an
association in a U.S. cohort.
Fourotherlongitudinalobservational
studies (2,3,5,8,9) have reported data on
the association between vitamin D status
and risk of developing type 2 diabetes.
Vitamin D was assessed by vitamin D in-
take in two studies (5,8) and by predicted
25-OHD score in another study (9). All
three studies reported an inverse associa-
tion between vitamin D status and inci-
dent type 2 diabetes. However, only one
study, using pooled data from two Finn-
ish cohorts, has reported the association
between blood 25-OHD concentration
andincidenttype2diabetes(2,3).Among
men, those in the highest quartile had a
72% lower risk of developing type 2 dia-
betes compared with men in the lowest
quartile, but there was no association
among women. In the Finnish cohorts,
men had higher baseline 25-OHD than
women (19 vs. 15 ng/ml, respectively),
while among women in the NHS, 25-
OHD was higher (23 ng/ml), which may
explain the lack of association among
women in the Finnish study.
There are no published clinical trials
designed to test the hypothesis that in-
creasing 25-OHD concentration prevents
new-onset type 2 diabetes. Only one trial
(Women’s Health Initiative) has exam-
ined, in a post hoc analysis, the effect of
400 IU of vitamin D versus placebo on
incident type 2 diabetes, and there was
no difference (1,10). However, that trial
used 400 IU/day vitamin D, which is
inadequate to raise 25-OHD concentra-
tion enough to see any effect.
The strengths of our study include its
longitudinal study design, large size,
long-term follow-up, the validated mea-
surements of the exposure and outcome,
and the availability of detailed informa-
tiononriskfactorsfortype2diabetesand
other covariates, including seasonality
and latitude. The major limitation of our
study is its observational nature; there-
fore, residual confounding cannot be ex-
cluded. Also, our results cannot be
directly extrapolated to men or nonwhite
women.
In conclusion, our ﬁndings suggest
that raising 25-OHD concentration may
be an effective strategy at reducing risk
of incident type 2 diabetes in women.
Because observational studies of vita-
min D have a high potential for con-
founding, our results need to be
conﬁrmedinrandomizedcontrolledtri-
als speciﬁcally designed to test such a
hypothesis.
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Table 1—OR for incident type 2 diabetes in women, according to plasma 25-OHD concentration
25-OHD quartile
P for trend* 1 (lowest) 2 3 4 (highest)
Plasma 25-OHD concentration
(ng/ml) median (range)† 14.4 (6.7–17.8) 20.8 (17.9–23.1) 25.9 (23.2–28.9) 33.4 (29.1–87.6)
n (case/control subjects) 201/140 193/145 139/144 75/140
OR (95% CI)
Crude‡ 1.00 (reference) 0.91 (0.67–1.24) 0.65 (0.47–0.90) 0.35 (0.25–0.51) 0.001
Multivariate model§ 1.00 (reference) 1.02 (0.71–1.47) 0.79 (0.54–1.16) 0.40 (0.26–0.62) 0.001
Multivariate model plus BMI 1.00 (reference) 1.09 (0.74–1.61) 0.95 (0.63–1.45) 0.52 (0.33–0.83) 0.008
*Statistical tests for trend were conducted using the median value of each quartile of plasma 25-OHD concentration as a continuous variable. †To convert 25-OHD
concentration from ng/ml to nmol/l multiplied by 2.459. ‡Adjusted for matching variables (age, race, fasting status, month of blood draw, and laboratory batch for
plasma 25-OHD). §Adjusted for everything in ‡ plus latitude (residence in southern states 40
oN; California, Florida, and Texas or northern states 40
oN;
Connecticut, Maryland, Massachusetts, Michigan, New Jersey, New York, Ohio, and Pennsylvania), history of hypercholesterolemia (yes or no), history of
hypertension (yes or no), family history of diabetes (yes or no), smoking status (never, past, or currently smoking), physical activity (METs/week, in quartiles),
alcoholconsumption(grams/day,inquartiles),multivitaminuse(yesorno),anddietaryvariablesinquartiles(caffeinemg/day,transfatg/day,cerealﬁberg/day,
heme iron mg/day, magnesium mg/day, ﬁsh servings/day, and calcium intake mg/day).
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